Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Lucia Del Mastro

dirigente medico

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (16)

Fabio Puglisi

Head of the Unit of Medical Oncology and Cancer Prevention

ITALY

View details

Marco Tagliamento

Researcher/Assistant Professor

University of Genoa

ITALY

View details

Joohyuk Sohn

Yonsei University College of Medicine

SOUTH KOREA

View details

Sara Santamaria

Ricercatore sanitario

Ospedale Policlinico San Martino

ITALY

View details

Eva M Fallenberg

Professor of Radiology

Technical University of Munich

GERMANY

View details

Evandro de Azambuja

Institut Jules Bordet

BELGIUM

View details

Nicola Tinari

Professore Associato

University of Chieti-Pescara

ITALY

View details

Elisa Agostinetto

Institut Jules Bordet

BELGIUM

View details

Peter Schmid

Professor of Cancer Medicine and Honorary Consultant in Medical Oncology, Centre Lead, Centre for Experimental Cancer Medicine

Barts Cancer Institute

UNITED KINGDOM

View details

Giorgio Mustacchi

Università degli Studi di Torino

ITALY

View details

CARMINE DE ANGELIS

Associate Professor

University of Naples Federico II

ITALY

View details

ida paris

Head of Breast Oncology Unit

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

ITALY

View details

Giampaolo Bianchini

Head Breast Cancer Group

IRCCS Ospedale San Raffaele

ITALY

View details

Damiano Gentile

Breast Surgeon

IRCCS Humanitas Research Hospital

ITALY

View details

Miguel Martin

Universidad Complutense de Madrid

SPAIN

View details

Nicola Fusco

Director

University of Milan

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lucia Del Mastro

Research Interests

Make your next move.

Explore related searches

Articles (20)

Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib

Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEX

OPERA-01: a phase III study of palazestrant for ER+, HER2-advanced breast cancer after CDK4/6 inhibitor therapy

Integrating<i> PIK3CA</i> Testing into Clinical Practice for Advanced HR+/HER2-Breast Cancer: An Expert Consensus

Overall survival with abemaciclib in early breast cancer

Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial

How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer

Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review

Immunotherapy for resectable NSCLC: neoadjuvant/perioperative followed by surgery over surgery followed by adjuvant. Systematic review and meta-analysis with subgroup analyses

Response to Venkataraman and Mokbel

Extended adjuvant endocrine therapy in early breast cancer: finding the individual balance

New insight in early detection and precision medicine in small cell lung cancer: liquid biopsy as innovative clinical tool

Letter response re: factors associated with first-to-second line attrition among patients with metastatic breast cancer in the real-world

Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus.

Clinical Evidence of Methods and Timing of Proper Follow-Up for Head and Neck Cancers

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study

Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial

Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations

Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer

Collaborators (16)

Fabio Puglisi

Marco Tagliamento

Joohyuk Sohn

Sara Santamaria

Eva M Fallenberg

Evandro de Azambuja

Nicola Tinari

Elisa Agostinetto

Peter Schmid

Giorgio Mustacchi

CARMINE DE ANGELIS

ida paris

Giampaolo Bianchini

Damiano Gentile

Miguel Martin

Nicola Fusco

Make your next move.